Nanospect (Human Serum Albumin)

Human Serum Albumin, the active ingredient in Nanospect, is a plasma expander presented as a sterile solution for intravenous and subcutaneous use. It increases plasma oncotic pressure and expands intravascular volume in patients who need rapid volume support.

GNH USA supplies Nanospect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Human Serum Albumin is used to manage conditions where plasma volume or albumin levels are deficient.

- Hypovolemia: restores intravascular volume and improves circulatory stability. - Severe burns: provides oncotic support to reduce edema and fluid loss. - Liver disease with hypoalbuminemia: raises serum albumin concentrations. - Major surgery or trauma: maintains hemodynamic balance during peri‑operative fluid shifts.

Human Serum Albumin may be associated with a range of adverse reactions.

Common Side Effects: - Fever or chills during infusion. - Mild hypotension or hypertension. - Headache or dizziness. - Nausea or vomiting. - Local irritation at the injection site. - Transient rash.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute hemolysis. - Volume overload leading to pulmonary edema. - Thromboembolic events. - Renal dysfunction. - Transmission of infectious agents (theoretical risk).

Human Serum Albumin should be administered with careful clinical monitoring.

- Assess fluid status: evaluate volume needs before infusion. - Monitor vital signs: watch for blood pressure changes during and after administration. - Use caution in cardiac failure: avoid excess volume that may worsen congestion. - Screen for albumin antibodies: consider prior reactions to blood products. - Adjust dose in renal or hepatic impairment: tailor volume based on organ function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Human Serum Albumin can interact with other agents that affect fluid balance or immune response.

Major Interactions (Avoid): - High‑dose diuretics: may precipitate severe hypovolemia. - Immunoglobulin preparations: increased risk of allergic reactions.

Moderate Interactions (Monitor Closely): - Vasopressors: may require dose adjustment due to altered hemodynamics. - Anticoagulants: monitor coagulation parameters as volume shifts can affect drug levels. - Other plasma expanders: avoid cumulative volume overload. - Certain antibiotics (e.g., aminoglycosides): monitor renal function closely.